Investors in Quest Diagnostics, Inc. (Symbol: DGX) saw new options become available today, for the January 2026 expiration. One of the key inputs that goes into the price an option buyer is ...

(RTTNews) - Quest Diagnostics Incorporated (DGX), a provider of diagnostic information services, Tuesday said it partnered with The University of Texas MD Anderson Cancer Center to develop a multi ...

Power conferences create NIL enforcement arm: Will the cheating end or just take a new form (which could look familiar)? The College Sports Commission will have the authority to regulate NIL deals.

Shares of Quest Diagnostics are trading at a forward earnings multiple of 17.9X, as well as a PEG Ratio of 2.4, a Price/Cash Flow ratio of 12.8X, and a Price/Sales ratio of 1.9X.